Michael KeyoungManaging Director, Head of North America at C-Bridge Capital
Dr. Keyoung has over 20 years of experience as a physician, investor and a healthcare executive. Dr. Keyoung joined CBC in 2017 as Managing Director and Head North America. He currently serves as Chairman of AffaMed Therapeutics and has served on the board of Everest Medicines and IMab, CBC portfolio companies. Prior to joining CBC, Dr. Keyoung was President and CEO of Genexine Inc., KOSDAQ listed billion-dollar biotech company. He was also Founding Managing Partner of Portola Capital Partners, President of Catalyst Biosciences (NASDAQ:CBIO), and Managing Director and head of Pan-Asia at Burrill & Company.
Dr. Keyoung received both his Medical Doctorate and Ph.D. in Neuroscience and Neurology from Cornell University Weill Medical College and Memorial Sloan Kettering Cancer Center and trained as a surgeon at UCSF Medical Center.